Nurse Practitioner · Topeka, KS
NPI
1063892677
Since 2015
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2200 SW 6th Ave, Suite 104
Topeka, KS, 66606
Phone (785) 354-8518
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
539 services
Medicare patients, 2024
322
Average age 72
Drug cost, 2024
$546K
2,218 prescriptions
Company payments, 2025
$1,559
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jayda M Rupp was code 99214 (office e&m - established), 254 times for 167 patients. In total Jayda M Rupp billed 539 services in 8 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-06-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 254 | 167 | $73.07 | $19K |
| 99213 Office E&M - Established | Office | 212 | 175 | $48.37 | $10K |
| 99204 Office E&M - New | Office | 54 | 54 | $81.19 | $4,384 |
| 99203 Office E&M - New | Office | 12 | 12 | $35.99 | $432 |
By year: 2022 $23K for 352 services; 2023 $34K for 544 services; 2024 $34K for 539 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jayda M Rupp prescribed most often to Medicare patients was Pantoprazole Sodium, with 619 prescriptions and refills. In total Jayda M Rupp wrote 2,218 Medicare prescriptions that cost $546K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 619 | 1,276 | 173 | $7,588 |
| Omeprazole Generic | 291 | 589 | 73 | $3,241 |
| Dicyclomine Hcl Generic | 149 | 216 | 37 | $2,991 |
| Erythromycin Erythromycin Base | 144 | 163 | 35 | $24K |
| Esomeprazole Magnesium Generic | 122 | 210 | 28 | $7,473 |
| Famotidine Generic | 110 | 256 | 37 | $1,059 |
| Linzess Linaclotide | 81 | 97 | 20 | $53K |
| Sulfasalazine Generic | 40 | 82 | Under 11 | $1,284 |
| Dexlansoprazole Dr Dexlansoprazole | 39 | 49 | Under 11 | $7,446 |
| Sucralfate Generic | 39 | 39 | Under 11 | $256 |
| Xifaxan Rifaximin | 38 | 38 | 14 | $117K |
| Ondansetron Odt Ondansetron | 36 | 36 | 12 | $1,045 |
| Ondansetron Hcl Generic | 35 | 37 | 18 | $187 |
| Colestipol Hcl Generic | 34 | 46 | Under 11 | $2,065 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 33 | 33 | 11 | $611 |
Brand drugs: - claims; generic drugs: 1,887 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jayda M Rupp $1,559 ($1,559 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $405.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 27 | $405 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 12 | $244 |
| Janssen Biotech, Inc. JNJ | 10 | $206 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 9 | $194 |
| QOL Medical, LLC | 4 | $97.05 |
| Madrigal Pharmaceuticals MDGL | 6 | $93.58 |
| Lilly USA, LLC LLY | 2 | $56.65 |
| Celltrion USA Inc. 068270.KS | 2 | $40.81 |
| Novo Nordisk Inc NVO | 2 | $38.53 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $36.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.